Kobayashi Atsushi, Satoh Sakae, Ironside James W, Mohri Shirou, Kitamoto Tetsuyuki
Division of CJD Science and Technology, Department of Prion Research, Center for Translational and Advanced Animal Research on Human Diseases, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.
Planova Division, Asahi Kasei Pharma Corporation, Tokyo, Japan.
J Gen Virol. 2005 Jan;86(Pt 1):237-240. doi: 10.1099/vir.0.80389-0.
In Creutzfeldt-Jakob disease (CJD), the type (type 1 or 2) of abnormal isoform of the prion protein (PrP(Sc)) in the brain and the genotype at codon 129 of the PrP gene are major determinants of clinicopathological phenotype. Little is known about the difference in biochemical properties between the two types of PrP(Sc), except for the different proteinase K cleavage sites. To investigate the size of aggregates formed by PrP(Sc) types 1 and 2, brain homogenates from various cases of CJD with the same genotype (homozygous for methionine at codon 129) were passed through filters with a mean pore size of 72+/-4 nm. Type 2 PrP(Sc) was efficiently removed from the filtrates by the filters, in contrast to type 1. Even type 2 PrP(Sc) from a patient without amyloid plaques was removed more efficiently than type 1 from patients with amyloid plaques. These results indicate that type 2 PrP(Sc) has a larger aggregation size than type 1, irrespective of the existence of amyloid plaques.
在克雅氏病(CJD)中,脑内朊蛋白(PrP(Sc))异常异构体的类型(1型或2型)以及PrP基因第129密码子处的基因型是临床病理表型的主要决定因素。除了蛋白酶K切割位点不同外,关于两种类型的PrP(Sc)生化特性的差异知之甚少。为了研究1型和2型PrP(Sc)形成的聚集体大小,将来自各种具有相同基因型(第129密码子处为甲硫氨酸纯合子)的CJD病例的脑匀浆通过平均孔径为72±4 nm的滤器。与1型相比,2型PrP(Sc)能被滤器有效地从滤液中去除。即使是来自没有淀粉样斑块患者的2型PrP(Sc),其去除效率也比来自有淀粉样斑块患者的1型PrP(Sc)更高。这些结果表明,无论淀粉样斑块是否存在,2型PrP(Sc)的聚集大小都比1型大。